We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NHR-176 regulates cyp-35d1 to control hydroxylation-dependent metabolism of thiabendazole in Caenorhabditis elegans.
- Authors
Jones, Laura M.; Flemming, Anthony J.; Urwin, Peter E.
- Abstract
Knowledge of how drugs are metabolized and excreted is an essential component of understanding their fate within and among target and non-target organisms. Thiabendazole (TBZ) was the first benzimidazole (BZ) to be commercially available and remains one of the most important anthelmintic drugs for medical and veterinary use. We have characterized how Caenorhabditis elegans metabolizes and excretes TBZ.We have shown that TBZ directly binds to the nuclear hormone receptor (NHR)-176 and that this receptor is required for the induction by TBZ of the cytochrome P450 (CYP) encoded by cyp-35d1. Further, RNAi inhibition of cyp-35d1 in animals exposed to TBZ causes a reduction in the quantity of a hydroxylated TBZ metabolite and its glucose conjugate that is detected in C. elegans tissue by HPLC. This final metabolite is unique to nematodes and we also identify two P-glycoproteins (PGPs) necessary for its excretion. Finally, we have shown that inhibiting the metabolismwe describe increases the susceptibility of C. elegans to TBZ in wild-type and in resistant genetic backgrounds.
- Subjects
THIABENDAZOLE; ANTHELMINTICS; CAENORHABDITIS elegans; NUCLEAR receptors (Biochemistry); RNA interference; HYDROXYLATION; DRUG metabolism; THERAPEUTICS
- Publication
Biochemical Journal, 2015, Vol 466, Issue 1, p37
- ISSN
0264-6021
- Publication type
Academic Journal
- DOI
10.1042/BJ20141296